A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.
NCT06163677 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-03-01
Summary
The main purpose of this study is to understand:
* the symptoms of COVID-19 or influenza
* health-related outcomes of people with COVID-19 or influenza
* the effects of vaccines in people with COVID-19 or influenza.
This study will take in participants who are:
* 18 years or older
* reported to have symptoms with lab tests that have confirmed illness. The lab tests can be tested at any of Walgreens pharmacy COVID-19 or influenza test sites.
The study will collect vaccine history information from participants who are ready to take part in the study. Participant will be emailed a form with questions about their health related to COVID-19 or influenza during twelve follow-ups over a 6-month period.
Conditions
Interventions
- BIOLOGICAL
-
Receipt of Pfizer BioNTech COVID-19 vaccine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-17
- Primary Completion
- 2024-01-17
- Completion
- 2024-01-17
- FDA Drug
- Yes
More Related Trials
-
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults
NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults
NCT06680375 ·Status: COMPLETED ·Phase: PHASE1
-
Response to Influenza Vaccine During Pregnancy
NCT03888989 ·Status: TERMINATED ·Phase: PHASE1
-
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
NCT04664075 ·Status: TERMINATED
-
A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza
NCT05227001 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
NCT06179446 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza
NCT05596734 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
NCT05972174 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
NCT02385123 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Evaluation of the Fluid Rapid Influenza Test
NCT00826709 ·Status: SUSPENDED ·Phase: PHASE3
-
A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults
NCT05827068 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old
NCT05375838 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
NCT05827978 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults
NCT06237049 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults
NCT04956575 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older
NCT06727058 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
NCT04806529 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
NCT05027932 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults
NCT05091307 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
NCT06097273 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
NCT00630331 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of Influenza Vaccinations
NCT06518577 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Influenza Vaccine Evaluation of Immune Response
NCT03598439 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older
NCT06907511 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2